1. Introduction
The membrane of most cells in the body is surrounded by a dynamically regulated, highly-hydrated fibrous meshwork of carbohydrates, known as pericellular matrix or glycocalyx. Its main constituents are several glycoconjugates (see nomenclature and definitions in Box 1), including glycolipids, the polysaccharide heparan sulfate (HS) linked to proteoglycan core proteins (e.g. glypican, syndecan, betaglycan), the polysaccharide hyaluronan and proteins bound to these polysaccharides.
Box 1. Nomenclature and definitions.
Glycoconjugates: Various types of compounds consisting of carbohydrates covalently linked with other types of chemical constituent.
Glycolipids: lipids with a carbohydrate attached by a covalent glycosidic bond. The carbohydrate portion may be a single monosaccharide or a linear or branched chain.
Glycoproteins: proteins containing oligosaccharide chains (glycans) covalently attached to amino acid side-chains; the carbohydrate portion consists of short chains, often branched.
Proteoglycans: proteins that are heavily glycosylated; the protein portion of the molecule represents only a small portion of the total molecular weight; the carbohydrate portion consists of long unbranched repeating disaccharide units (glycosaminoglycans, a.k.a. mucopolysaccharides). The three major classes of proteoglycans, characterized by their side chains, are the heparan sulfate proteoglycans, chondroitin sulfate proteoglycans, and keratan sulfate proteoglycans.
Polysaccharides: polymeric carbohydrate molecules composed of relatively long chains of monosaccharide units bound together by glycosidic linkages.
Lipopolysaccharides: large molecules consisting of a lipid and a polysaccharide composed of O-antigen, outer core, and inner core joined by a covalent bond; they are typically found in the outer membrane of Gram-negative BACTERIA. They are also known as lipoglycans and endotoxins.
Peptidoglycans: polymers consisting of a mino acids and specific sugars — alternating residues of β-(1,4) l inked N-acetylglucosamine (NAG) and N-acetylmuramic acid NAM) — that form a mesh-like layer outside the plasma membrane of most BACTERIA; they are also known as mureins.
2. Heparan sulfate proteoglycans: key components of the extracellular matrix
HS is a sulfated glycosaminoglycan polysaccharide produced by nearly all animal species; it is a linear polysaccharide essential for the organization of protein-receptor interactions at the cell surface and for the creation of chemotactic gradients of growth factors and chemokines. Besides being a crucial component of basement membranes, HS proteoglycans regulate the interaction of numerous signaling molecules (including growth factors, cytokines, chemokines, morphogens, proteases, and other proteins) with their specific receptors [1].
HS proteoglycans can be classified into four different families based on their location, their attachments to membranes, and their core protein structures. Glypicans are membrane-associated glycosyl-phosphatidylinositol (GPI)-anchored proteins; syndecans are transmembrane spanning proteins; secreted forms (including agrin, perlecan, collagen XVIII) are associated with the extracellular matrix (ECM); serglycin granules are present in intracellular storage granules.
3. Heparanase: a powerful multitasking enzyme
The only mammalian endoglycosidase capable of degrading HS is known as heparanase (HPSE); when released into the ECM, HPSE degrades HS cleaving polymeric HS molecules; additionally, this ubiquitously expressed enzyme is involved in a number of intracellular processes including autophagy, endocytosis, gene transcription, and secretion of exosomes [2–4]. HPSE is an endo-β-glucuronidase of the Carbohydrate Active Enzymes (CAZy) Glycoside Hydrolase (GH)79 family.
Within lysosomes and late endosomes, HPSE performs an essential housekeeping role in catabolic processing of internalized HS proteoglycans. Furthermore, HPSE can be trafficked to the cell surface or released into the ECM where it mediates breakdown of extracellular pools of HS: thus, latent pools of growth factors stored by HS are released, promoting increased cell proliferation, motility, and angiogenesis. Therefore, in addition to being an enzyme, HPSE has also non-enzymatic functions, like the ability to trigger different signaling pathways by interacting with specific transmembrane proteins.
4. Structural insights
Two genes encode for HPSE, HPSE1 and HPSE2, although the latter lacks enzymatic activity [5] and seems to act predominantly as a negative regulator of heparanase. The HPSE1 gene is located on chromosome 4 in humans (chromosome 5 in mice); it is expressed as two mRNA transcripts by alternative splicing, HPSE1a (5 kb) and HPSE1b (1.7 kb), which have the same open reading frames and encode the same 543 amino-acid polypeptides. HPSE is synthesized as a 68 kDa pre-proHPSE, the expression of which is mainly transcriptionally regulated. Pre-proHPSE is targeted to the endoplasmic reticulum via its N-terminal signal peptide, which is then cleaved to produce a 65 kDa proHPSE; the proHPSE is eventually transported to the Golgi apparatus where it is packaged into vesicles and secreted [6].
The crystal structures of human HPSE has been recently solved at 1.6–1.9 Å resolution [7], revealing a (β/α) 8 domain and a β-sandwich domain, and showing that an endo-acting binding cleft is exposed by proteolytic activation of latent proHPSE; the recognized cleavage site is a trisaccharide accommodated into the HPSE binding cleft and sulfation is essential for HPSE interaction with HS. The C-terminal domain of the 50 kDa subunit has been demonstrated to regulate protein secretion, enzymatic and non-enzymatic activity of HPSE.
5. Activation of HPSE
The HPSE1 promoter in normal cells and tissues is constitutively silenced by methylation and the actions of p53. Instead, HPSE1 is constitutively active in trophoblast, keratinocytes, and activated leukocytes and mast cells. HPSE expression can also be induced in other cell types by reactive oxygen species (ROS), components of the renin–angiotensin–aldosterone system (RAAS), endothelin 1, glucose, estrogens, certain p53 variants, and inflammatory mediators such as IL-1β, TNFα, and NF-kB [8]. Conversely, cellular quiescence induced by nitric oxide (NO) suppresses HPSE production, as does anti-inflammatory intracellular signaling through the vitamin D receptor. The ECM remodeling mediated by HPSE elicits the diffusion of cytokines, lipoproteins, and growth factors, facilitate cell motility, inflammation, angiogenesis, and coagulation.
Importantly, as mentioned above, HPSE also exhibits non-enzymatic activity: for instance, the pro-enzyme of 65 kDa stimulates signaling cascades that enhance phosphorylation of specific proteins including Akt, Src, and ERK. These HPSE-mediated processes have been demonstrated to play a pivotal role in cell adhesion, migration, and invasion in different cell types. More recently, HPSE has been also shown to regulate exosome production [4,9,10] and autophagy [11]. Low density lipoprotein (LDL) receptor-related proteins and mannose 6 phosphate receptors mediate the uptake of secreted proHPSE [12]; intracellular HPSE can localize to autophagosomes, where it positively stimulates the autophagic process through a non-enzymatic mechanism that involves downregulation of mTOR1 activity [6,11]. Notably, HPS activity is dependent on an acidic environment; indeed, bafilomycin A1 and chloroquine, which are known to raise the lysosomal pH, block HPSE enzymatic activity [13].
Upon lysosome permeabilization and via interaction with the chaperone heat shock protein 90, active HPSE can also translocate in the nucleus, where it degrades nuclear HS and regulates gene expression.
6. Mechanistic roles of HPSE in human disease
HPSE has been mainly involved in cancer progression, with studies demonstrating its contribution to motility, invasion, and metastasis [14]. The functional role of HPSE in cardiovascular disease has been especially investigated in the context of vascular injury: indeed, HPSE has been shown to be a critical mediator of thrombosis following angioplasty and stent-induced flow disturbance [15]. Aldi and colleagues in this issue of Atherosclerosis elegantly show that HPSE may have dual functions in vascular calcification, depending on the stage of the disease and the presence of inflammatory cells [16]: while HPSE plausibly enhances mineralization and osteogenic differentiation of vascular smooth muscle cells, it is associated with inflammation-induced osteoclast differentiation and activity in advanced atherosclerotic plaques.
In the nervous system, HS proteoglycans are crucial for the regulation of synaptic plasticity and have been shown to modulate the activity of calcium channels [17] and thereby neuronal firing rates; moreover, brain endothelial HS proteoglycans can modulate leukocyte migration across the blood-brain barrier and contribute to the formation of neuro-inflammatory lesions; a role for HPSE has been also inferred in multiple sclerosis and in prion disease [18]. Furthermore, HPSE has been implied in the pathogenesis of glomerulonephritis [6], pancreatic β cell failure and diabetes mellitus and its complications [19]. By regulating HS-bioavailability, HPSE is also involved in the pathogenesis of viral-mediated disorders: indeed, numerous human and non-human viruses utilize HS as an attachment co-receptor to entry into host cells [20].
Financial support
Gaetano Santulli, MD, PhD is supported by the National Institutes of Health (Grant DK107895) and by the Einstein-Mount Sinai Diabetes Research Center (Grant ES-DRC-P&F).
Footnotes
Conflict of interest
The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.
Contributor Information
Jun Shu, Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA.
Gaetano Santulli, Department of Medicine and Department of Molecular Pharmacology, The Wilf Family Cardiovascular Research Institute, New York, NY, USA; “The Norman Fleischer Institute for Diabetes and Metabolism”, Einstein-Sinai Diabetes Research Center, Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY, USA; Department of Biomedical Advanced Sciences, “Federico II” University, Naples, Italy.
References
- [1].Gutter-Kapon L, Alishekevitz D, Shaked Y, et al. , Heparanase is required for activation and function of macrophages, Proc. Natl. Acad. Sci. U. S. A 113 (2016) E7808–E7817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Naparstek Y, Cohen IR, Fuks Z, et al. , Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase, Nature 310 (1984) 241–244. [DOI] [PubMed] [Google Scholar]
- [3].Nakajima M, Irimura T, Di Ferrante N, et al. , Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase, J. Biol. Chem 259 (1984) 2283–2290. [PubMed] [Google Scholar]
- [4].Thompson CA, Purushothaman A, Ramani VC, et al. , Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes, J. Biol. Chem 288 (2013) 10093–10099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Vlodavsky I, Gross-Cohen M, Weissmann M, et al. , Opposing functions of heparanase-1 and heparanase-2 in cancer progression, Trends Biochem. Sci 43 (2018) 18–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Rabelink TJ, van den Berg BM, Garsen M, et al. , Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease, Nat. Rev. Nephrol 13 (2017) 201–212. [DOI] [PubMed] [Google Scholar]
- [7].Wu L, Viola CM, Brzozowski AM, et al. , Structural characterization of human heparanase reveals insights into substrate recognition, Nat. Struct. Mol. Biol 22 (2015) 1016–1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Sorriento D, Illario M, Finelli R, et al. , To NFkappaB or not to NFkappaB: the dilemma on how to inhibit a cancer cell fate regulator, Transl Med UniSa 4 (2012) 73–85. [PMC free article] [PubMed] [Google Scholar]
- [9].Roucourt B, Meeussen S, Bao J, et al. , Heparanase activates the syndecan-syntenin-ALIX exosome pathway, Cell Res 25 (2015) 412–428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Bandari SK, Purushothaman A, Ramani VC, et al. , Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior, Matrix Biol 65 (2018) 104–118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Shteingauz A, Boyango I, Naroditsky I, et al. , Heparanase enhances tumor growth and chemoresistance by promoting autophagy, Cancer Res 75 (2015) 3946–3957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Vreys V, Delande N, Zhang Z, et al. , Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans, J. Biol. Chem 280 (2005) 33141–33148. [DOI] [PubMed] [Google Scholar]
- [13].Zetser A, Levy-Adam F, Kaplan V, et al. , Processing and activation of latent heparanase occurs in lysosomes, J. Cell Sci 117 (2004) 2249–2258. [DOI] [PubMed] [Google Scholar]
- [14].Weissmann M, Bhattacharya U, Feld S, et al. , The heparanase inhibitor PG545 is a potent anti-lymphoma drug: mode of action, Matrix Biol (2018), 10.1016/j.matbio.2018.08.005 In press. [DOI] [PubMed] [Google Scholar]
- [15].Baker AB, Gibson WJ, Kolachalama VB, et al. , Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance, J. Am. Coll. Cardiol 59 (2012) 1551–1560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Aldi S, Eriksson L, Kronqvist M, et al. , Dual roles of heparanase in human carotid plaque calcification, Atherosclerosis (2019), 10.1016/j.atherosclerosis.2018.12.027 In press. [DOI] [PubMed] [Google Scholar]
- [17].Garau G, Magotti P, Heine M, et al. , Heparin/heparan sulfates bind to and modulate neuronal L-type (Cav1.2) voltage-dependent Ca(2+) channels, Exp. Neurol 274 (2015) 156–165. [DOI] [PubMed] [Google Scholar]
- [18].Minge D, Senkov O, Kaushik R, et al. , Heparan sulfates support pyramidal cell excitability, synaptic plasticity, and context discrimination, Cerebr. Cortex 27 (2017) 903–918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Ziolkowski AF, Popp SK, Freeman C, et al. , Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes, J. Clin. Invest 122 (2012) 132–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Hadigal SR, Agelidis AM, Karasneh GA, et al. , Heparanase is a host enzyme required for herpes simplex virus-1 release from cells, Nat. Commun 6 (2015) 6985. [DOI] [PMC free article] [PubMed] [Google Scholar]